Your browser doesn't support javascript.
loading
Using a Health Information Exchange to Characterize Changes in HIV Viral Load Suppression and Disparities During the COVID-19 Pandemic in New York City.
Tucker, Emma; Reyes Nieva, Harry; Schiffer, Kayla; Yin, Michael T; Castor, Delivette; Gordon, Peter; Elhadad, Noémie; Zucker, Jason.
Afiliação
  • Tucker E; Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Reyes Nieva H; Department of Biomedical Informatics, Columbia University, New York, New York, USA.
  • Schiffer K; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Yin MT; Department of Biomedical Informatics, Columbia University, New York, New York, USA.
  • Castor D; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
  • Gordon P; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
  • Elhadad N; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
  • Zucker J; Department of Biomedical Informatics, Columbia University, New York, New York, USA.
Open Forum Infect Dis ; 10(12): ofad584, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38156044
ABSTRACT

Background:

HIV viral suppression requires sustained engagement in care. The COVID-19 pandemic challenged care accessibility for many people living with HIV (PLWH). We used health information exchange data to evaluate the effect of pandemic-related disruptions in HIV care on viral load suppression (VLS) and to examine racial/ethnic disparities in VLS.

Methods:

We performed a retrospective observational cohort study of PLWH using data from a regional health information exchange in the New York City region between 1 January 2018 and 31 December 2022. We established 2 cohorts PLWH who received HIV care in 2020 (cohort A) and PLWH who did not receive HIV care in 2020 (cohort B). We categorized HIV VLS outcomes as suppressed or not suppressed and calculated the prevalence of VLS between 2018 and 2022. We compared proportions using chi-square tests and used unadjusted and adjusted logistic regression to estimate the association among variables, including race/ethnicity, cohort, and VLS.

Results:

Of 5 301 578 patients, 34 611 met our inclusion criteria for PLWH, 11 653 for cohort A, and 3141 for cohort B. In 2019, cohort B had a lower prevalence of VLS than cohort A (86% vs 89%, P < .001). Between 2019 and 2021, VLS dropped significantly among cohort B (86% to 81%, P < .001) while staying constant in cohort A (89% to 89%, P = .62). By 2022, members of cohort B were less likely than cohort A to be receiving HIV care in New York City (74% vs 88%, P < .001). Within both cohorts, Black and Hispanic patients had lower odds of VLS than White patients.

Conclusions:

In New York City, VLS remained high among PLWH who continued to receive care in 2020 and dropped among PLWH who did not receive care. VLS was lower among Black and Hispanic patients even after controlling for receipt of care.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos